Immediate Impact
64 standout
Citing Papers
Management of ALL in adults: 2024 ELN recommendations from a European expert panel
2024 Standout
Engineering IL-2 for immunotherapy of autoimmunity and cancer
2022 Standout
Works of Guido Gini being referenced
Imatinib for refractory chronic graft-versus-host disease with fibrotic features
2009
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Guido Gini | 233 | 202 | 89 | 180 | 36 | 612 | |
| D Guyotat | 139 | 120 | 150 | 266 | 52 | 642 | |
| Kazuki Tanimoto | 324 | 244 | 83 | 111 | 45 | 624 | |
| Daniel El Fassi | 233 | 35 | 177 | 171 | 36 | 703 | |
| Gavivann Veerakul | 91 | 127 | 158 | 245 | 34 | 736 | |
| Sinan Yavuz | 87 | 182 | 67 | 132 | 47 | 596 | |
| Lene Dissing Sjø | 483 | 336 | 107 | 99 | 34 | 729 | |
| WY Au | 98 | 96 | 103 | 298 | 42 | 529 | |
| Tatiana Nevskaya | 278 | 91 | 53 | 40 | 32 | 615 | |
| Fengchun Zhang | 63 | 250 | 42 | 29 | 29 | 724 | |
| Ilenia Pantano | 149 | 50 | 44 | 211 | 25 | 697 |
All Works
Login with ORCID to disown or claim papers
Loading papers...